Merck spends $11.5B for Acceleron, possible blockbuster drug - NewsBreak

Merck will spend about $11.5 billion to buy Acceleron Pharma and its potential treatment for high blood pressure in vessels that connect the lungs and heart. Merck will pay $180 per share in cash for Acceleron, the Kenilworth, New Jersey, company said Thursday. Acceleron is running late-stage studies of a...